Endocan and Asymmetric Dimethylarginine as an Etiological Indicator in the Maternal and Umbilical Cord Serum in Pre-Eclampsia

Creative Commons License

İNANDIKLIOĞLU N., BAŞER E., AYDOĞAN KIRMIZI D.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.59, no.4, pp.308-312, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 59 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.4274/haseki.galenos.2021.7101
  • Journal Name: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.308-312
  • Keywords: N, N-dimethylarginine, preeclampsia, pregnancy, proteoglycans, umbilical cord, NITRIC-OXIDE SYNTHESIS, PLASMA-CONCENTRATIONS, ENDOGENOUS INHIBITOR, NORMAL-PREGNANCY, ADMA, SEVERITY, SYNTHASE, WOMEN
  • Yozgat Bozok University Affiliated: Yes

Abstract

Aim: Preeclampsia is a pregnancy-specific disease of unknown etiology. This study was planned to determine the place of asymmetric dimethylarginine (N, N-dimethylarginine, ADMA) and endothelial cell specific molecule-1 (ESM1, endocan) levels in etiology. The aim of this study was to determine ADMA and endocan levels in maternal and fetal umbilical cord serum of patients with preeclampsia and to evaluate them with clinical data.